Changes in liver gangliosides in streptozotocin-induced diabetic rats

Cell Biology International

Volumn 24, Issue 12, 2000, Pages 897-904

  Sanchez S S ^a   Abregu A V ^a   Aybar, M J ^a   Sanchez Riera A N ^a  

^a Instituto Superior de Investigaciones Biologicas   (Argentina)

Author keywords

Diabetes; Gangliosides; Liver; Rat; Streptozotocin

Indexed keywords

GALACTOSYLTRANSFERASE; GANGLIOSIDE; GLUCOSE; GLYCOGEN; INSULIN ZINC SUSPENSION; MONOTARD MC NOVO; N ACETYLGALACTOSAMINYLTRANSFERASE; SIALYLTRANSFERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; GLYCOGEN METABOLISM; HISTOPATHOLOGY; LIPID METABOLISM; LIVER INJURY; LIVER MICROSOME; MALE; NONHUMAN; PATHOGENESIS; RAT; STREPTOZOCIN DIABETES; THIN LAYER CHROMATOGRAPHY;

ANIMALIA;

EID: 0034525045     PISSN: 10656995     EISSN: None     Source Type: Journal    
DOI: 10.1006/cbir.1999.0452     Document Type: Article

References (53)

1. Expression of glycosphingolipids glycosyltransferases in development and transformation
2. Biological specificity of sialyltransferases
3. The enzymatic synthesis of gangliosides. II. UDP-Galactose:N-Acetylgalactosaminyl-(N-acetyl-neuraminyl) galactosyl-glucosyl-ceramide galactosyltransferase in rat brain
4. Regulation of ganglioside metabolism by phosphorylation and dephosphorylation
5. Genetic polymorphism of rat liver gangliosides
6. Hepatomegaly and abnormal liver test due to glycogenosis in adults with diabetes
7. Protein kinase C is activated in glomeruli from streptozotocin diabetic rats. Possible mediation by glucose
8. GD3 ganglioside is prevalent in fully differentiated neurons from rat retina
9. Proliferation and hypertrophy of liver cells surrounding islet grafts in diabetic recipient rats
10. The effect of diabetes mellitus on sterol synthesis in the intact rat
11. Disorders of gastrointestinal motility associated with diabetes mellitus
12. A simple method for the isolation of total lipids from animal tissues
13. Glycolipid patterns during Xenopus embryo development
14. Activities of glycolipid glycosyltransferases and sialidases during the early development of Xenopus laevis
15. Regulation of sialyltransferase activities by phosphorylation and dephosphorylation
16. Proliferation of fetal rat hepatocytes in response to growth factors and hormones in primary culture
17. Isolation and characterization of a new fucoganglioside accumulated in precancerous rat liver and in rat hepatoma induced by N-2acetylaminofluorene
18. Protein kinase C activation and its role in the development of vascular complications in diabetes mellitus
19. Decreased autophosphorylation of the insulin receptor-kinase in streptozotocin-diabetic rats
20. Evidence for a role of insulin in hepatocytic differentiation of human hepatoma BC1 cells
21. Insulin as a potent, specific growth factor in a rat hepatoma cell line
22. Glycolipids: Structure and function
23. Developmental profiles of gangliosides in trisomy 19 mice
24. Protein measurement with the Folin phenol reagent
25. Thermotropic characterization of phosphatidylcholine vesicles containing ganglioside GM1 with homogeneous ceramide chain length
26. Changes in hepatic glutathione metabolism in diabetes
27. Gangliosides of liver tumors induced by N-2-Fluorenylacetamide. I. Ganglioside alterations in liver tumorigenesis and normal development
28. Sialyltransferase activities in cultured rat hepatocytes
29. Alternations of diacylglycerol kinase in steptozotocin-induced diabetic rats
30. Serum lipoproteins and cholesterol metabolism in two hypercholesterolaemic rabbit models
31. Glycosphingolipid glycosyltransferases in human fetal brain
32. Decrease of liver protein kinase C in steptozotocin-induced diabetic rats and restoration by vanadate treatment
33. Changes of the human liver GM3 ganglioside molecular species during aging
34. Developmental expression of gangliosides in vivo and in vitro
35. Impaired antioxidant status in diabetic rat liver: Effect of vanadate
36. Altered biosynthesis of gangliosides in developing biliary cirrhosis in the rat
37. Altered concentrations, patterns and distribution in lipoproteins of serum gangliosides in liver diseases of different etiologies
38. Ganglioside biosynthesis in rat liver: Different distribution of ganglioside synthases in hepatocytes. Kupffer cells, and sinusoidal endothelial cells
39. Ganglioside biosynthesis in mouse embryos: Sialyltransferase IV and the asialo pathway
40. Chromatographic separation of human brain gangliosides
41. Immunohistochemical localization of ganglioside components in hepatocellular carcinoma and liver cirrhosis using monoclonal antibody
42. Ganglioside variations in human liver cirrhosis and hepatocellular carcinoma as shown by two-dimensional thin-layer chromatography
43. Insulin modulation of acute-phase protein production in a human hepatoma cell line
44. Two glycosphingolipid syalyltransferases are localized in different sub-Golgi compartments in rat liver
45. The onset of liver glycogen synthesis in fasted-refed rats. Effects of streptozotocin diabetes and of peripheral insulin replacement
46. Ganglioside metabolism. Enzymology, topology and regulation
47. Enzymes of myo-inositol and inositol lipid metabolism in rats with streptozotocin-induced diabetes
48. The gangliosides
49. Protein kinase C activity is altered in diabetic rat hearts
50. 20-sphingosine as a determining factor in aggregation of gangliosides
51. Development regulation of ganglioside metabolism
52. A role for glycophingolipid accumulation in the renal hypertrophy of streptozotocin-induced diabetes mellitus
53. GM3 directly inhibits tyrosine phosphorylation and de-N-acetyl-GM3 directly enhances serine phosphorylation of epidermal growth factor receptor interaction